Patents by Inventor Stephen Michael Mahler

Stephen Michael Mahler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD83 antibodies and use thereof
    Patent number: 11725054
    Abstract: The present disclosure relates to proteins that bind to CD83 and uses thereof, for example, in therapy, prophylaxis, diagnosis, or prognosis.
    Type: Grant
    Filed: July 9, 2020
    Date of Patent: August 15, 2023
    Assignees: KIRA BIOTECH PTY LIMITED, THE UNIVERSITY OF QUEENSLAND, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Therese Ann Seldon, David John Munster, Derek Nigel John Hart, Martina Louise Jones, Trent Phillip Munro, Stephen Michael Mahler, Yu Zhou, James D. Marks
  • ANTI-CD83 ANTIBODIES AND USE THEREOF
    Publication number: 20200339684
    Abstract: The present disclosure relates to proteins that bind to CD83 and uses thereof, for example, in therapy, prophylaxis, diagnosis, or prognosis.
    Type: Application
    Filed: July 9, 2020
    Publication date: October 29, 2020
    Applicants: DENDROCYTE BIOTECH PTY LTD, THE UNIVERSITY OF QUEENSLAND, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Therese Ann Seldon, David John Munster, Derek Nigel John Hart, Martina Louise Jones, Trent Phillip Munro, Stephen Michael Mahler, Yu Zhou, James D. Marks
  • Anti-CD83 antibodies and use thereof
    Patent number: 10781255
    Abstract: The present disclosure relates to proteins that bind to CD83 and uses thereof, for example, in therapy, prophylaxis, diagnosis or prognosis.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: September 22, 2020
    Assignees: DENDROCYTE BIOTECH PTY LTD, THE UNIVERSITY OF QUEENSLAND, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Therese Ann Seldon, David John Munster, Derek Nigel John Hart, Martina Louise Jones, Trent Phillip Munro, Stephen Michael Mahler, Yu Zhou, James D. Marks
  • ANTI-CD83 ANTIBODIES AND USE THEREOF
    Publication number: 20180201681
    Abstract: The present disclosure relates to proteins that bind to CD83 and uses thereof, for example, in therapy, prophylaxis, diagnosis or prognosis.
    Type: Application
    Filed: November 9, 2017
    Publication date: July 19, 2018
    Applicants: DENDROCYTE BIOTECH PTY LTD, THE UNIVERSITY OF QUEENSLAND, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Therese Ann Seldon, David John Munster, Derek Nigel John Hart, Martina Louise Jones, Trent Phillip Munro, Stephen Michael Mahler, Yu Zhou, James D. Marks
  • Anti-CD83 antibodies and use thereof
    Patent number: 9840559
    Abstract: The present disclosure relates to proteins that bind to CD83 and uses thereof, for example, in therapy, prophylaxis, diagnosis, or prognosis.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: December 12, 2017
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE UNIVERSITY OF QUEENSLAND, DENDROCYTE BIOTECH PTY LTD
    Inventors: Therese Ann Seldon, David John Munster, Derek Nigel John Hart, Martina Louise Jones, Trent Phillip Munro, Stephen Michael Mahler, Eunice Yu Zhou, James D. Marks
  • ANTI-CD83 ANTIBODIES AND USE THEREOF
    Publication number: 20150376277
    Abstract: The present disclosure relates to proteins that bind to CD83 and uses thereof, for example, in therapy, prophylaxis, diagnosis, or prognosis.
    Type: Application
    Filed: January 31, 2014
    Publication date: December 31, 2015
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Therese Ann Seldon, David John Munster, Derek Nigel John Hart, Martina Louise Jones, Trent Phillip Munro, Stephen Michael Mahler, Eunice Yu Zhou, James D. Marks
  • COMPOSITIONS FOR PROTEIN DELIVERY VIA THE PULMONARY ROUTE
    Publication number: 20090022669
    Abstract: Novel formulations comprising therapeutic agents, a surface tension-controlling agent, and a component that comprises both a humectant and a viscosity-controlling agent for use in thermal droplet ejecting devices are disclosed. The formulations are useful for maintaining controlled and reliable dosage of the therapeutic agent via pulmonary delivery.
    Type: Application
    Filed: June 20, 2008
    Publication date: January 22, 2009
    Inventors: Michael John Waters, Stephen Michael Mahler, Hak-Kim Chan, Stephen Francis Goodall, Nora Y.K. Chew
  • Compositions for protein delivery via the pulmonary route
    Publication number: 20030064052
    Abstract: Novel formulations comprising therapeutic agents, a surface tension-controlling agent, and a component that comprises both a humectant and a viscosity-controlling agent for use in thermal droplet ejecting devices are disclosed. The formulations are useful for maintaining controlled and reliable dosage of the therapeutic agent via pulmonary delivery.
    Type: Application
    Filed: May 21, 2002
    Publication date: April 3, 2003
    Applicant: Ponwell Enterprises, Ltd.
    Inventors: Michael John Waters, Stephen Michael Mahler, Hak-Kim Chan, Stephen Francis Goodall, Nora Y.K. Chew